期刊文献+

四种药物治疗细菌性阴道炎的药物经济学评价 被引量:4

The pharmacoeconomic evaluations of four drugs in the treatment of bacterial vaginitis
原文传递
导出
摘要 目的探讨硝呋太尔制霉素栓、乳酸菌阴道胶囊、双唑泰阴道泡腾片及聚甲酚醛栓四种药物治疗细菌性阴道炎的成本效果,为临床合理用药提供指导。方法随机选取分别使用硝呋太尔制霉素栓(92例)、乳酸菌阴道胶囊(88例)、双唑泰阴道泡腾片(90例)及聚甲酚醛栓(91例)治疗的细菌性阴道炎门诊患者361例,比较用药一个疗程的治疗效果、用药成本及不良反应,运用药物经济学成本.效果分析法评价四种治疗方案的成本效果。结果硝呋太尔制霉素栓、乳酸菌阴道胶囊、双唑泰阴道泡腾片及聚甲酚醛栓总有效率分别为78.26%、76.14%、83.33%、78.02%,四组总有效率差异无统计学意义(P〉0.05);双唑泰阴道泡腾片具有最小的成本一效果比(C/E,0.26)。结论从药物经济学角度来看,双唑泰阴道泡腾片是治疗细菌性阴道炎的较佳选择。 Objective To investigate the cost-effectiveness of four drugs in treatment of bacterial vaginitis and improve clinic rational drug use. Methods 361 bacterial vaginitis out-patients were treated with lactobacillus vaginal effervescent tablets(92 cases), lacidophilin vaginal capsules (88 cases), shuangzuotai vaginal effervescent tablets (90 cases), metronidazole vaginal effervescent tablets (91 cases). The therapeutic effect, drug cost and therapeutic effect were evaluated by cost effectiveness analysis 7d after treatment. Results The overall response rate of lactoba- cillus vaginal effervescent tablets, lacidophilin vaginal capsules, shuangzuotai vaginal effervescent tablets, metronidazole vaginal effervescent tablets were 78.26% ,76.14% , 83.33 % and 78.02%, respectively. The overall response rate was no significant difference between four groups(0.06), and metronidazole vaginal effervescent tablets had the lowest cost effectiveness rate ( C/E, 0. 26). Conclusion The metronidazole vaginal effervescent tablets is better schedule in treatment of bacterial vaginitis.
作者 郭宇
出处 《中国基层医药》 CAS 2013年第8期1184-1186,共3页 Chinese Journal of Primary Medicine and Pharmacy
关键词 细菌性阴道炎 药物治疗 药物经济学 Bacterial vaginitis Pharmacotherapy Pharmacoeconomic
  • 相关文献

参考文献6

二级参考文献22

  • 1张玉坤.细菌性阴道炎40例临床分析[J].医学理论与实践,2005,18(6):689-690. 被引量:11
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8242
  • 3杨世杰.药理学[M].北京:人民卫生出版社,2006:121-125,301-302.
  • 4[1]王淑珍.实用妇产科学.人民卫生出版社,1993:262.
  • 5American Thoracic Society.Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ven-tilator-associated,and heahhcare-associated pneumonia[J].Am J Reapir Crit Care Med,2005,171:388-416.
  • 6American Thoracic Society.Infectious Diseases Society of America.Guidelines for the management of adults with hospital-acquired,ven-tilator-associated,and healthcare-associated pneumonia[J].Am J Respir Crit care Med,2005,171(4):388-416.
  • 7FORSUM U,HALLEN A,LARSSON P G.Bacterial vaginosis-a boratory and clinical diagnostics enigma [ J ]. APMIS, 2005,113 ( 3 ) :153-161.
  • 8PAVLOVA S I,KILIC A O, MOU S M,et al. Phage infection in vaginal lactobacilli:an in vitro study[ J ]. Infect Dis Obstet Gynecol, 1997,5:244-251.
  • 9McCLEAN N W,McGROARTY J A.Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by lactobacilli in vitro[J].Appl Environ Microbiol,1996,62:1089-1092.
  • 10WILSON J. Mallaging recurrent bacterial vaginosis[ J]. Sex Transm Infect ,2004,80 ( 1 ) :8-11.

共引文献44

同被引文献50

二级引证文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部